Diabetes Identification (ADA) - Diabetes Prevention and Management (ADA)

Diabetes Identification (ADA) Standards of Care in Diabetes—Part 1: Summary for General Practice Source: American Diabetes Association; Medically Reviewed by Dr Roger Henderson The American Diabetes Association (ADA) has updated its guidance on standards of care in diabetes for 2025.[1] This guideline overview for GPs, the first in a series on this comprehensive guideline, focuses on the clinical presentation, classification, identification, and diagnosis of diabetes with reference to other key guidance on diabetes management. The recommendations cover the management of type 1 diabetes, type 2 diabetes, gestational diabetes, and other forms of diabetes or hyperglycaemia in all age groups. •Characteristics of prediabetes https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a100074f?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681 •Screening with risk calculators https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a100074f?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681#1 •Determining type and severity https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a100074f?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681#1 Diabetes Prevention and Management (ADA) Standards of Care in Diabetes—Part 2: Summary for General Practice Source: American Diabetes Association; Medically Reviewed by Dr Roger Henderson In 2024, the American Diabetes Association (ADA) published guidance on standards of care in diabetes.[1] This guideline overview, the second in a series, focuses on the prevention and management of diabetes and its complications in all age groups, with reference to other key guidance on diabetes management. •Type 1 vs type 2 prevention https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a1000an1?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681 •Optimal timing for T2D therapy https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a1000an1?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681 •Key T2D combo therapies https://reference.medscape.com/cc2/p10/guideline-essentials-2025-american-diabetes-association-2025a1000an1?ecd=WNL_drugguide_251218_MSCPREF_endo_etid7963681&uac=148436CN&impID=7963681